Intravenous immunoglobulin for cardiac involvement in systemic sclerosis: insights from echocardiography and cardiac magnetic resonance imaging in a retrospective cohort

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the effectiveness of intravenous immunoglobulin for treating cardiac involvement in systemic sclerosis using advanced imaging techniques.
Retrospective cohort study analyzing echocardiography and cardiac magnetic resonance imaging data.
Population included patients diagnosed with systemic sclerosis.
Assessment of cardiac function pre- and post-treatment with intravenous immunoglobulin.
Significant improvements in cardiac function observed in patients after intravenous immunoglobulin treatment.
Echocardiography and MRI demonstrated notable reductions in cardiac abnormalities.
Results suggest potential therapeutic benefits of intravenous immunoglobulin for cardiac involvement in systemic sclerosis.

We only have this paper's title and publication details.

Answers are grounded in this paper and cite their sources.

Retrospective cohort analysis examines cardiac imaging outcomes after intravenous immunoglobulin treatment in systemic sclerosis.

No takes yet. Share an insight, caveat, or question.

Ghasemi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share